# A Pilot Study of Hemoporfin PDT in Children With Port-wine Stain

> **NCT03125057** · PHASE4 · COMPLETED · sponsor: **Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Port-wine Stain

## Interventions

- **DRUG:** Hemoporfin PDT

## Key facts

- **NCT ID:** NCT03125057
- **Lead sponsor:** Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-02
- **Primary completion:** 2020-05-10
- **Final completion:** 2020-05-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2020-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03125057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03125057, "A Pilot Study of Hemoporfin PDT in Children With Port-wine Stain". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03125057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*